CIBC Private Wealth Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$835 Hold
58
﹤0.01% 2953
2025
Q3
$923 Sell
58
-42
-42% -$692 ﹤0.01% 2832
2025
Q2
$1.77K Buy
+100
New +$1.95K ﹤0.01% 2670
2024
Q3
Sell
-4
Closed -$78 3136
2024
Q2
$78 Hold
4
﹤0.01% 3095
2024
Q1
$73 Buy
+4
New +$73 ﹤0.01% 3017

Other funds holding BTAL

CIBC Private Wealth Group's BTAL Position: Q4 2025 in Review

CIBC Private Wealth Group held its AGF US Market Neutral Anti-Beta Fund (BTAL) position steady in Q4 2025 at 58 shares worth $835. The position accounts for ﹤0.01% of the portfolio, ranked #2953.

CIBC Private Wealth Group first reported a position in BTAL in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.77K in Q2 2025. 81 funds tracked by Wall St. Rank hold BTAL as of Q4 2025.

  • CIBC Private Wealth Group held 58 shares of AGF US Market Neutral Anti-Beta Fund worth $835 as of Q4 2025.
  • CIBC Private Wealth Group left its AGF US Market Neutral Anti-Beta Fund share count unchanged in Q4 2025.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2953 holding.
  • CIBC Private Wealth Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2024 and has held it in 5 quarters since.
  • CIBC Private Wealth Group's AGF US Market Neutral Anti-Beta Fund position peaked at $1.77K in Q2 2025.
  • 81 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.